Share this post on:

Product Name :
Lipoic acid/Trometamol

Search keywords :
α-Lipoic Acid

drugId :
null

Target Vo:
Unidentified

Target Vo Short Name :
Unidentified

Moa_Name:
Undisclosed

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Jiangsu Aosaikang Pharmaceutical Co Ltd

Active Company_Name :
Jiangsu Aosaikang Pharmaceutical Co Ltd

Active Indication_Name:
Paresthesia

In Active Indication_Name:
Diabetic Neuropathies

Termination Status :

China Termination Status :

Highest Status:
Phase 2 Clinical

China Highest Status:
Phase 2 Clinical

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
HMGB1 Rabbit mAb Purity & Documentation
Calnexin Rabbit mAb Autophagy
Phospho-EGFR (Y1068) Antibody (YA204): Phospho-EGFR Antibody (YA204) is a non-conjugated and Rabbit origined monoclonal antibody about 134 kDa, targeting to Phospho-EGFR(Y1068). It can be used for WB,ICC/IF,IP,FC assays with tag free, in the background of Human.

Share this post on:

Author: Interleukin Related